13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001596452
Total reported value
$131.7M
$131.7M
34 檔
29.6%
At the close of Q1 2026, Sivik Global Healthcare LLC disclosed equity holdings valued at approximately $131.7M, spread across 34 reported holdings.
In Q1 2026, Sivik Global Healthcare LLC adopted a defensive or profit-taking posture, trimming 24 positions and completely liquidating 22 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 14.55% | — | -33.33% | |
| 2 | CAH | Cardinal Health Inc | Stock-Healthcare | 3.85% | — | -26.15% | |
| 3 | ✓ | Call- Bsx 100 @ 75 Exp 04/17/2026 | Stock-Other | 3.81% | — | — | |
| 4 | JNJ | Johnson & Johnson | Stock-Healthcare | 3.71% | — | — | |
| 5 | MRK | Merck & Co. Inc. | Stock-Healthcare | 3.65% | — | +33.33% | |
| 6 | COR | Cencora Inc | Stock-Healthcare | 3.58% | — | -16.67% | |
| 7 | LLY | Eli Lilly & Co | Stock-Healthcare | 3.49% | — | -28.57% | |
| 8 | WAT | Waters CORP | Stock-Healthcare | 3.39% | — | — | |
| 9 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 3.39% | — | -27.38% | |
| 10 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.15% | — | -10.00% | |
| 11 | AZN | AstraZeneca PLC | Stock-Healthcare | 3.00% | — | — | |
| 12 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 2.99% | — | -33.33% | |
| 13 | BSX | Boston Scientific CORP | Stock-Healthcare | 2.95% | — | -11.43% | |
| 14 | DHR | Danaher CORP | Stock-Healthcare | 2.88% | — | -13.04% | |
| 15 | THC | Tenet Healthcare CORP | Stock-Healthcare | 2.87% | — | -46.67% | |
| 16 | GILD | Gilead Sciences Inc | Stock-Healthcare | 2.65% | — | — | |
| 17 | HUM | Humana Inc | Stock-Healthcare | 2.63% | — | +33.33% | |
| 18 | MTD | Mettler-toledo International | Stock-Healthcare | 2.63% | — | -8.33% | |
| 19 | MCK | Mckesson CORP | Stock-Healthcare | 2.63% | — | -55.56% | |
| 20 | A | Agilent Technologies Inc | Stock-Healthcare | 2.60% | — | -14.29% | |
| 21 | SYK | Stryker CORP | Stock-Healthcare | 2.50% | — | -23.08% | |
| 22 | ABBV | Abbvie Inc | Stock-Healthcare | 2.48% | — | -25.00% | |
| 23 | UHS | Universal Health Services-b | Stock-Healthcare | 2.38% | — | -37.50% | |
| 24 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 2.35% | — | — | |
| 25 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 2.12% | — | -16.67% | |
| 26 | BIIB | Biogen Inc | Stock-Healthcare | 2.09% | — | -25.00% | |
| 27 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 2.05% | — | -16.67% | |
| 28 | GMED | Globus Medical Inc - A | Stock-Healthcare | 1.96% | — | -25.00% | |
| 29 | ABT | Abbott Laboratories | Stock-Healthcare | 1.95% | — | -37.50% | |
| 30 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.22% | — | -42.86% | |
| 31 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 1.21% | — | -60.00% | |
| 32 | ELV | Elevance Health Inc | Stock-Healthcare | 1.11% | — | — | |
| 33 | EHC | Encompass Health CORP | Stock-Healthcare | 1.10% | — | -70.00% | |
| 34 | CVS | Cvs Health CORP | Stock-Healthcare | 1.09% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | +6.6% | -33.33% | Trim |
| 2 | MRK | Merck & Co. Inc. | +2.7% | +33.33% | Add |
| 3 | CAH | Cardinal Health Inc | +1.9% | -26.15% | Trim |
| 4 | COR | Cencora Inc | +1.8% | -16.67% | Trim |
| 5 | GILD | Gilead Sciences Inc | +1.8% | — | Unchanged |
| 6 | VRTX | Vertex Pharmaceuticals Inc | +1.6% | -27.38% | Trim |
| 7 | HUM | Humana Inc | +1.5% | +33.33% | Add |
| 8 | ISRG | Intuitive Surgical Inc | +1.5% | -10.00% | Trim |
| 9 | MTD | Mettler-toledo International | +1.4% | -8.33% | Trim |
| 10 | DHR | Danaher CORP | +1.4% | -13.04% | Trim |
| 11 | LLY | Eli Lilly & Co | +1.3% | -28.57% | Trim |
| 12 | A | Agilent Technologies Inc | +1.2% | -14.29% | Trim |
| 13 | SYK | Stryker CORP | +1.2% | -23.08% | Trim |
| 14 | ABBV | Abbvie Inc | +1.2% | -25.00% | Trim |
| 15 | BIIB | Biogen Inc | +1.1% | -25.00% | Trim |
| 16 | BIO | Bio-rad Laboratories-a | +1.1% | -16.67% | Trim |
| 17 | BSX | Boston Scientific CORP | +1% | -11.43% | Trim |
| 18 | TMO | Thermo Fisher Scientific Inc | +1% | -33.33% | Trim |
| 19 | GMED | Globus Medical Inc - A | +1% | -25.00% | Trim |
| 20 | UNH | Unitedhealth Group Inc | +0.9% | -16.67% | Trim |
| 21 | THC | Tenet Healthcare CORP | +0.7% | -46.67% | Trim |
| 22 | UHS | Universal Health Services-b | +0.6% | -37.50% | Trim |
| 23 | ABT | Abbott Laboratories | +0.5% | -37.50% | Trim |
| 24 | MCK | Mckesson CORP | +0.5% | -55.56% | Trim |
| 25 | EW | Edwards Lifesciences CORP | +0.4% | -42.86% | Trim |
| 26 | SNN | Smith & Nephew PLC -spon Adr | 0% | -60.00% | Trim |
| 27 | EHC | Encompass Health CORP | -0.4% | -70.00% | Trim |
| 28 | ✓ | Put - Spy 100 @ 684 Exp 01/30/2026 | — | EXIT | Sold out |
| 29 | ✓ | Put - Spy 100 @ 679 Exp 01/30/2026 | — | EXIT | Sold out |
| 30 | ✓ | — | EXIT | Sold out | |
| 31 | ✓ | — | EXIT | Sold out | |
| 32 | ✓ | Put - Spy 100 @ 682 Exp 02/20/2026 | — | EXIT | Sold out |
| 33 | ✓ | — | EXIT | Sold out | |
| 34 | ✓ | — | EXIT | Sold out | |
| 35 | ✓ | Put - Spy 100 @ 681 Exp 01/30/2026 | — | EXIT | Sold out |
| 36 | HCA | Hca Healthcare Inc | — | EXIT | Sold out |
| 37 | ✓ | Call- Bsx 100 @ 75 Exp 04/17/2026 | — | NEW | New buy |
| 38 | JNJ | Johnson & Johnson | — | NEW | New buy |
| 39 | WAT | Waters CORP | — | NEW | New buy |
| 40 | MDT | Medtronic plc | — | EXIT | Sold out |
| 41 | RGEN | Repligen CORP | — | EXIT | Sold out |
| 42 | AZN | AstraZeneca PLC | — | NEW | New buy |
| 43 | BDX | Becton Dickinson And Co | — | EXIT | Sold out |
| 44 | NVO | Novo-nordisk A/s-spons Adr | — | EXIT | Sold out |
| 45 | AZNN | Astrazeneca Plc-spons Adr | — | EXIT | Sold out |
| 46 | REGN | Regeneron Pharmaceuticals | — | NEW | New buy |
| 47 | SGRY | Surgery Partners Inc | — | EXIT | Sold out |
| 48 | BRKR | Bruker CORP | — | EXIT | Sold out |
| 49 | GEHC | GE Healthcare Technology | — | EXIT | Sold out |
| 50 | SEM | Select Medical Holdings CORP | — | EXIT | Sold out |
According to official SEC Form 13F filings, Sivik Global Healthcare LLC reported a total U.S. public equity portfolio value of $131.7M across 34 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026) accounted for 29.6% of total reported equity market value during Q1 2026.
Top New Position Initiated
CALL- BSX 100 @ 75 EXP 04/17/2026
市值: $5.0M
Top Position Liquidated / Trimmed
PUT - SPY 100 @ 684 EXP 01/30/2026
前期市值: $20.5M
During Q1 2026, Sivik Global Healthcare LLC's top holdings by market value included XBI (14.6%)、CAH (3.9%)、CALL- BSX 100 @ 75 EXP 04/17/2026 (3.8%). The largest single position, XBI, represented 14.6% of total portfolio value.
In Q1 2026, Sivik Global Healthcare LLC made 55 total portfolio adjustments, initiating 7 new buys, adding to 2 positions, trimming 24 holdings, and fully liquidating 22 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.